Abstract
In 2008, the U.S. market for drug eluting stents was valued at $1.95 billion,
representing an increase of 1.6% over 2007. Overall average selling prices are
predicted to decrease over the forecast period. Additional products included
in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.
Table of Contents
U.S. MARKET FOR DRUG-ELUTING AND BARE METAL STENTS 2009
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
- 1.1 MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
- 1.2 BARE-METAL AND DRUG-ELUTING STENTS
- 1.3 PTCA AND CUTTING BALLOONS
- 1.4 BALLOON-INFLATION SYRINGES AND ANGIOPLASTY KITS
- 1.5 INTERVENTIONAL CATHETERS
- 1.6 INTERVENTIONAL GUIDEWIRES
- 1.7 EMBOLIC PROTECTION DEVICES
- 1.8 ATHERECTOMY DEVICES
- 1.9 THROMBECTOMY DEVICES
- 1.10 CHRONIC TOTAL OCCLUSION CROSSERS
- 1.11 INTRODUCER SHEATHS
- 1.12 VASCULAR CLOSURE DEVICES
- 1.13 DIAGNOSTIC CORONARY CATHETERS AND GUIDEWIRES
- 1.14 FRACTIONAL FLOW RESERVE GUIDEWIRES
- 1.15 IVUS CATHETERS
- 1.16 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
- 1.17 VULNERABLE PLAQUE DEVICES
- 1.18 PFO, ASD AND VSD DEVICES
- 1.19 PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
- 1.20 AORTIC HEART VALVE REPLACEMENT DEVICES
- 1.21 LEADING COMPETITORS
RESEARCH METHODOLOGY
- 2.1 RESEARCH SCOPE
- 2.2 IDATA' S 9-STEP METHODOLOGY
- 2.2.1 Step 1: Project Initiation & Team Selection
- 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
- 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
- 2.2.4 Step 4: Performing Primary Research
- 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
- 2.2.6 Step 6: Market Forecast and Analysis
- 2.2.7 Step 7: Identify Strategic Opportunities
- 2.2.8 Step 8: Final Review and Market Release
- 2.2.9 Step 9: Customer Feedback and Market Monitoring
BARE-METAL AND DRUG-ELUTING STENTS
- 3.1 INTRODUCTION
- 3.2 POPULATION AT RISK
- 3.3 PROCEDURE NUMBERS
- 3.4 MARKET ANALYSIS & FORECAST
- 3.4.1 Units Sold by Type
- 3.4.2 Bare-Metal Stent Market
- 3.4.2.1 Bare-Metal Stent Market Drivers
- 3.4.2.2 Bare-Metal Stent Market Limiters
- 3.4.3 Drug-Eluting Stent Market
- 3.4.3.1 Drug-Eluting Stent Market Drivers
- 3.4.3.2 Drug-Eluting Stent Market Limiters
- 3.4.4 Stents in Development
- 3.4.4.1 Bioabsorbable Stents
- 3.4.4.2 Bifurcated Stents
- 3.5 STENT MARKET BY DELIVERY PLATFORM
- 3.6 STENT MARKET BY SIZE
- 3.7 COMPETITIVE ANALYSIS
- 3.7.1 Bare-Metal Stents
- 3.7.2 Drug-Eluting Stents
- 3.7.3 Potential New Market Participants
ABBREVIATIONS
LIST OF FIGURES
- EXECUTIVE SUMMARY
- RESEARCH METHODOLOGY
- BARE-METAL AND DRUG-ELUTING STENTS
- Figure 4-1: Population at Risk, Market for Interventional Cardiology,
U.S., 2005- 2015
- Figure 4-2: Angiography and Angioplasty Procedures, U.S., 2005 - 2015
- Figure 4-3: Market for Coronary Stents by Type, U.S., 2005 - 2015
- Figure 4-4: Units Sold, Market for Coronary Stents, U.S., 2005 - 2015
- Figure 4-5: Coronary Stent Units by Type, U.S., 2005 - 2015
- Figure 4-6: Market for Bare-Metal Stents, U.S., 2005 - 2015
- Figure 4-7: Market Drivers and Limiters, Market for Bare-Metal Stents,
U.S., 2008
- Figure 4-8: Market for Drug-Eluting Stents, U.S., 2005 - 2015
- Figure 4-9: Market Drivers and Limiters, Market for Drug-Eluting Stents,
U.S., 2008
- Figure 4-10: Coronary Stent Platforms in Development Not Approved by the
FDA, 2008
- Figure 4-11: Potential Market for Bioabsorbable Stents, U.S., 2013 - 2015
- Figure 4-12: Potential Market for Bifurcated Stents, U.S., 2010 - 2015
- Figure 4-13: Market for Coronary Stents by Delivery Platform, Units Sold,
U.S., 2005 - 2015
- Figure 4-14: Market for Coronary Stents by Size, U.S., 2008
- Figure 4-15: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
- Figure 4-16: Leading Competitors, U.S. Market for Drug-Eluting Stents, 2008
- ABBREVIATIONS
LIST OF CHARTS
- EXECUTIVE SUMMARY
- Chart 1-1: Market for Interventional Cardiology Devices, U.S., 2008
- Chart 1-2: Market for Coronary Stents, U.S., 2005 - 2015
- Chart 1-3: Coronary Atherectomy Devices Market, U.S., 2005 - 2015
- Chart 1-4: Coronary CTO Crosser Market, U.S., 2005 - 2015
- Chart 1-5: Coronary Vascular Closure Devices, U.S., 2005 - 2015
- Chart 1-6: Market for Diagnostic Coronary Catheters and Guidewires, U.S.,
2005 - 2015
- Chart 1-7: Penetration Rate of FFR Guidewires in PCI Procedures, U.S.,
2005 2015
- Chart 1-8: Number of IVUS Catheter Units Sold, U.S., 2005 - 2015
- Chart 1-9: Optical Coherence Tomography Catheter Market, U.S., 2010 - 2015
- Chart 1-10: Leading Competitors, Market for Interventional Cardiology,
U.S., 2008
- RESEARCH METHODOLOGY
- BARE-METAL AND DRUG-ELUTING STENTS
- Chart 4-1: Population at Risk, Market for Interventional Cardiology, U.S.,
2005 - 2015
- Chart 4-2: Age Group Most Likely to Undergo Cardiac Intervention: 60 to 69
Years Old, U.S., 2005 - 2015
- Chart 4-3: Angioplasty and Angiography Procedures, U.S., 2005 - 2015
- Chart 4-4: Market for Coronary Stents by Type, U.S., 2005 - 2015
- Chart 4-5: Coronary Stent Units by Type, U.S., 2005 - 2015
- Chart 4-6: Market for Bare-Metal Stents, U.S., 2005 - 2015
- Chart 4-7: Market for Drug-Eluting Stents, U.S., 2005 - 2015
- Chart 4-8: Penetration Rate for Bioabsorbable Stents, U.S., 2013 - 2015
- Chart 4-9: Penetration Rate for Bifurcated Stents, U.S., 2010 - 2015
- Chart 4-10: Market for Coronary Stents by Delivery Platform, Units Sold,
U.S., 2005 - 2015
- Chart 4-11: Market for Coronary Stents by Size, U.S., 2008
- Chart 4-12: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
- Chart 4-13: Leading Competitors, Market for Drug-Eluting Stents, U.S., 2008
- ABBREVIATIONS
|
相關報告
|
